Today's Updates

Asian Women With Breast Cancer Outlive White Peers
Published Date: 02 Jul 2026

Researchers seek to understand why Asian women fare better with the disease.

Read More
FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD
Published Date: 02 Jul 2026

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Read More

Latest News

Medline Draws Another US FDA Warning in Two Months Over Quality Lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

Boehringer Ingelheim Launches AI Centre for Pharma Research in London

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

How Much Do Long Wait Times Cost Canadian Patients?

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

Virtual Physiotherapy Shows Promise for Chronic Cough

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Germans Trust ‘Dr AI’ More Than Doctors Who Use It

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

Neurology Clinics are Adopted by Genetic Therapies.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Thermo Fisher Issues a Warning About the Squeeze in Biotech Funding.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

Brain implant for patients with paralysis to undergo human trial.

Neuralink, an Elon Musk-founded brain-chip startup, announced on Tuesday that it has been given the go-ahead to start recruiting for a human trial of its brain implant after receiving approval from an impartial review board.

Customers of CarePath are notified by IBM of unauthorized data access.

According to IBM, a "data incident" involving unauthorized access to personal data is being reported to Janssen CarePath customers, a Johnson and Johnson division.

Near-Term Elimination of NHP Supply Snarls: Charles River.

Wednesday's second-quarter earnings from Charles River Laboratories International exceeded Wall Street expectations.

Roflumilast Cream is Safe and Effective for Psoriasis in Children.

For kids with psoriasis under the age of 12, only a few topical treatments are permitted. ".

For consumers, Quest Diagnostics has introduced a blood test for Alzheimer's.

The first direct-to-consumer blood test to identify abnormal levels of beta amyloid, a crucial protein in Alzheimer's disease, was released by Quest Diagnostics on Monday.

Laut einer Studie hilft Kombucha bei Typ-2-Diabetes.

Even though the study lacked sufficient power to draw firm conclusions, the popular fermented tea lowered blood glucose levels.

For the purpose of developing new drugs, Nvidia invests millions.

According to a statement released on Wednesday, Nvidia invested $50 million to expedite the training of artificial intelligence models for drug discovery developed by biotech company Recursion.

$920 million in manufacturing deals for Pfizer are announced by Samsung Biologics.

On Tuesday, Samsung Biologics of South Korea announced two agreements to produce goods for Pfizer worth a combined 1 trillion won ($921 million).

EU Could Lose Advantage With Proposed Law, Pharma Lobby Group Warns.

If a proposed EU health package is not altered, China, emerging markets, and the US could become more competitive, hurting Europe's pharmaceutical industry.

Latest News

Medline Draws Another US FDA Warning in Two Months Over Quality Lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

Boehringer Ingelheim Launches AI Centre for Pharma Research in London

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

How Much Do Long Wait Times Cost Canadian Patients?

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

Virtual Physiotherapy Shows Promise for Chronic Cough

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Germans Trust ‘Dr AI’ More Than Doctors Who Use It

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

Neurology Clinics are Adopted by Genetic Therapies.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Thermo Fisher Issues a Warning About the Squeeze in Biotech Funding.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

Brain implant for patients with paralysis to undergo human trial.

Neuralink, an Elon Musk-founded brain-chip startup, announced on Tuesday that it has been given the go-ahead to start recruiting for a human trial of its brain implant after receiving approval from an impartial review board.

Customers of CarePath are notified by IBM of unauthorized data access.

According to IBM, a "data incident" involving unauthorized access to personal data is being reported to Janssen CarePath customers, a Johnson and Johnson division.

Near-Term Elimination of NHP Supply Snarls: Charles River.

Wednesday's second-quarter earnings from Charles River Laboratories International exceeded Wall Street expectations.

Roflumilast Cream is Safe and Effective for Psoriasis in Children.

For kids with psoriasis under the age of 12, only a few topical treatments are permitted. ".

For consumers, Quest Diagnostics has introduced a blood test for Alzheimer's.

The first direct-to-consumer blood test to identify abnormal levels of beta amyloid, a crucial protein in Alzheimer's disease, was released by Quest Diagnostics on Monday.

Laut einer Studie hilft Kombucha bei Typ-2-Diabetes.

Even though the study lacked sufficient power to draw firm conclusions, the popular fermented tea lowered blood glucose levels.

For the purpose of developing new drugs, Nvidia invests millions.

According to a statement released on Wednesday, Nvidia invested $50 million to expedite the training of artificial intelligence models for drug discovery developed by biotech company Recursion.

$920 million in manufacturing deals for Pfizer are announced by Samsung Biologics.

On Tuesday, Samsung Biologics of South Korea announced two agreements to produce goods for Pfizer worth a combined 1 trillion won ($921 million).

EU Could Lose Advantage With Proposed Law, Pharma Lobby Group Warns.

If a proposed EU health package is not altered, China, emerging markets, and the US could become more competitive, hurting Europe's pharmaceutical industry.

News All Time

Gastroenterology Exam Is a Failure for ChatGPT Bot.

The AI language-processing model did not pass a self-assessment test with a minimum passing grade of 70% and is not advised for use in medical education.

Hippocratic AI Raises Funds to Create Healthcare Models.

A startup developing artificial intelligence models for the healthcare sector, Hippocratic AI, has raised $50 million in a larger-than-normal seed funding round.

WHO Issues Warning Against Misinformation When Using AI in Healthcare.

On Tuesday, the World Health Organization warned against using AI in public healthcare because the data it uses to make decisions may be biased or misapplied.

US Jury Rules in Favor of Natera in Cancer-Detection Patent Case.

Monday, a federal jury in Delaware was persuaded to award genetic testing company Natera Inc. $19.3 million in damages from Invitae Corp.'s ArcherDX for infringing patents pertaining to cancer detection.

Changes in Hypertrophic Cardiomyopathy Risk Stratification?

Data show that compared to 24-hour monitoring, extended ECG monitoring detects a higher incidence of clinically relevant arrhythmias.

New Trials in Breast Cancer: Could Your Patient Benefit?

Perhaps one of your patients qualifies to participate in a clinical trial that is currently looking for breast cancer patients.

The Musk Animal Testing Panel Is Riddled With Possibilities.

A board overseeing animal research has been staffed by insiders from Elon Musk's brain-implant business who could profit financially as the company advances.

Drugmakers increase their research spending and look for deals.

As the larger players in the sector look for new sources of long-term revenue, drugmakers announced on Thursday that they are open to acquisitions and that their R&D spending has increased.

EU Law Reform Could Lead to a Shift in Investments: GSK.

The European Union's pharmaceutical industry is governed by new laws, which the British pharmaceutical company GSK warned on Wednesday run the risk of driving businesses to innovate and invest elsewhere.

Proposed Drug Law Reforms Published by the EU.

On Wednesday, Brussels released a long-awaited draft of its proposed overhaul of the laws governing the pharmaceutical industry in the European Union, setting off a dispute with drugmakers who threaten to invest and innovate elsewhere.

BioNTech and DualityBio will develop cancer drugs worth more than $1.5 billion

German company BioNTech said on Monday that it has signed an agreement with Chinese biotech company DualityBio to jointly develop and commercialize two cancer drug candidates.

Musk's brain transplant company seeks human collaboration

Elon Musk's neuroimplantation company Neuralink has reached one of the largest neurosurgical centers in the country capable of testing partners as it plans to test human devices if the regulator.

FDA moves to quickly approve gene therapy

The FDA is making important changes to gene therapy development, including encouraging the use of biomarkers that help recommend treatments for serious conditions, FDA officials said.

AI pab kwv yees ulcerative colitis remission/activity, relapse.

AI tools can distinguish between functional and histological clearance and predict the severity of ulcerative colitis biopsies, and can play a role in clinical trials and routine practice.

The fall of SVB casts a shadow over the beginnings of American biotechnology

The Silicon Valley banking meltdown will leave biotech start-ups with different funding options, investors and analysts said Monday.

SVB shock could have chilling effect on UK biotech sector

HSBC's bailout of the UK branch of the Silicon Valley bank has saved Britain's main biotech sector from collapse, but funding a sector the government sees as essential for the growth of the future economy could be affected, according to industry executives.

Recommended News For You

Six breast texture patterns linked to higher risk of invasive cancer

Pickleball program boosts health and wellness for cancer survivors, study finds

Dual-action mRNA vaccine takes aim at aggressive skin cancer

A radiotheranostic approach designed to combat aggressive cancers

Kate Middleton Reaches Cancer Treatment Milestone

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

Recommended Articles For You

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Engineered Red Blood Cell Therapeutics: Emerging Applications 

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome 

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

2.

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

For treatment, the majority of cancer patients choose complementary therapies.

1.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

2.

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology

3.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

4.

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide

5.

Adaptive Rehabilitation Strategies for Advanced Cancer Survivorship

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part IV


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot